Document:

EX-10.2

 Exhibit 10.2 
  

 
 EMPLOYMENT CONTRACT 

between 
 Orthofix AG 

c/o ALLconsultServices 
 Bundesstrasse 3 

CH-6304 Zug 
 (referred to in the following as
“Employer” or “Company”) 
 and 

Davide Bianchi 
 born on 14 April 1965 

Chemin du Mont Blanc 4 
 1272 Genolier, Switzerland 

(referred to in the following as “Employee”) 

  
 Page 1 of 19 

			
	

	  	Employment Contract

  

 § 1 Start, Place of Work and Relocation 

The Employee will join effective 22. July 2013 (the “Effective Date”) as President of International Extremity Fixation and will report to the
Chief Executive Officer of Orthofix International N.V. 
 His office will be in the Verona subsidiary of Orthofix (i.e. Orthofix Srl). At the discretion of
the Employer, the employee’s place of work may be changed to other subsidiaries of the company, also at a different location inside Europe. The Employee may be asked but will not be obliged to relocate his place of living. 

It is also at the Employer’s discretion to move the Employee to a different function which corresponds with his skills and knowledge, or to change the
scope of the position, or to change the reporting line. This, however, cannot lead to a decrease in remuneration. 
 § 2 Work Hours 

Regular work hours per week are 40 hours. 
 The duration of the
daily work as well as start and finish time is at the discretion of the Employer. 
 The Employee agrees, in accordance with business requirements as well
as legal limits, to work overtime as well as to work on Sundays and bank holidays. Upon request of the overtime, the Employer has to consider the business needs as well as the rights of the Employee. Overtime is covered inside the remuneration
package. 
 § 3 Term of Contract and Termination 

Notice of six (6) months to terminate the contract of employment can be given by either party to take effect as of the end of a calendar month. 

The Employer has the right to release the Employee from work in the case of a termination, by either party, until the end of the notice period, continuing any
contractual payments. 
 The employment contract ends without the need for notice, no later than the end of the month in which the employee reaches the
legal retirement age (currently age 65). It also ends with the day on which the worker receives an early retirement pension or a full pension for disability. 

§ 3a Termination without Cause; Termination for Good Reason by the Employee. 

A one-time lump sum severance payment in an amount equal to 100% of the gross annual base salary and the average of the last three years bonus payout plus, for
a termination by the Employee for Good Reason (please refer to Exhibit B for definitions) or a termination by the Company without Cause only, CHF 11.500,— to be used by the Employee for outplacement services. The lump sum severance payment
shall be paid on the 60th day following the Employee’s termination of employment, provided that prior to such time the Executive has signed the release described in Exhibit A and the applicable revocation period for such release has expired,
subject, in the case of termination other than as a result of the Executive’s death. 

  
 Page 2 of 19 

			
	

	  	Employment Contract

  

 A termination without cause and a termination for good reason by the employee has to be given with 30 days
notice. 
 § 3b Termination for Cause. 
 If at any
time during the Term the Employee’s employment with the Company is terminated by the Employer for Cause (refer to Appendix for definition), the Employee shall be entitled to the following: 

 

	 	a)	any unpaid base salary and accrued unpaid vacation then owing through the date of termination, which amounts shall be paid to the Employee within 30 days of the date of termination. 

 

	 	b)	whatever rights, if any, that are available to the Employee upon such a termination pursuant to the Plans or any award documents related to any stock-based compensation such as stock options, stock appreciation rights
or restricted stock grants. This Agreement does not grant any greater rights with respect to such items than provided for in the Plans or the award documents in the event of any termination for Cause or a Voluntary Termination. 

For a termination for cause there is no notice period, it comes into effect immediately. 

§ 3c Termination following Change of Control 
 The
Employee shall have no specific right to terminate this Agreement or right to any severance payments or other benefits solely as a result of a Change of Control or Potential Change of Control. However, if during a Change of Control Period during the
Term, (a) the Employee terminates his employment with the Company for Good Reason, or (b) the Company terminates the Employee’s employment without Cause, a lump sum severance payment in the amount of 150% of the gross annual
base salary shall be paid to the Employee. No other rights result from termination during a Change of Control Period; provided, however, that nothing in this Section is intended to limit or impair the rights of the Employee under the Plans or any
documents evidencing any stock-based compensation awards in the event of a Change of Control if such Plans or award documents grant greater rights than are set forth herein. 

§ 4 Remuneration. 
 The gross annual base salary of
the Employee amounts to CHF 330.000.— (three hundred and thirty thousand Swiss Francs); this equals a monthly base salary of CHF 27.500.— (twenty seven thousand five hundred Swiss Francs). The monthly base salary is payable in arrears at
the end of the calendar month. 
 The premium contribution to the corporate pension scheme of the Employer is compliant with the requirement of the Swiss
Occupational Pension Legislation BVG (Berufsvorsorgegesetz). The annual premium depends on the amount of the salary and the age of the Employee. At the present time, it is about CHF 56’400. Two-thirds of the Premium is paid by the Employer and
one third by the Employee. The Employee’s contribution is deducted from the salary in monthly installments of about CHF 1.600,—. In Addition, the Employee will receive further a voluntary contributions to the 3rd column in the amount of CHF 6.739,— per annum. 

  
 Page 3 of 19 

			
	

	  	Employment Contract

  

 § 4a Variable Compensation 

With respect to each fiscal year of the Company during the Term, the Employee shall be eligible to receive annual bonus compensation under the Parent’s
Employee Annual Incentive Plan or any successor plan (the “Bonus Plan”) based on the achievement of goals established by the Board from time to time (the “Goals”). During the Term, the Employee will have a target bonus
opportunity under the Bonus Plan of at least 60% of his then-applicable Base Salary and an opportunity to earn a maximum annual bonus of not less than 90% of his then-applicable Base Salary; provided, however, the Employee’s bonus under the
Annual Incentive Plan with respect to work performed during the 2013 calendar year shall be pro-rated based on the number of days employed during the 2013 calendar year. The amount of any actual payment will depend upon the achievement (or not) of
the Goals established by the Board. Except as otherwise provided in this Agreement, to receive a bonus under the Bonus Plan, the Employee must be employed on the date of payment of such bonus. Amounts payable under the Bonus Plan shall be determined
by the Board and shall be paid following such fiscal year and no later than two and one-half months after the end of such fiscal year. In addition, the Employee shall be eligible to receive such additional bonus or incentive compensation as the
Board may establish from time to time in its sole discretion. Any bonus or incentive compensation under this Section under the Bonus Plan or otherwise is referred to herein as “Incentive Compensation.” Stock-based compensation shall not be
considered Incentive Compensation under the terms of this Agreement unless the parties expressly agree otherwise in writing. 
 § 4b Stock
Compensation 
 The Employee shall be eligible to receive stock-based compensation, whether stock options, stock appreciation rights, restricted stock
grants or otherwise, under the Parent’s 2012 Long Term Incentive Plan or other stock-based compensation plans as Parent may establish from time to time (collectively, the “Plans”). The Employee shall be considered for such grants no
less often than annually as part of the Board’s annual compensation review, but any such grants shall be at the sole discretion of the Board. Notwithstanding the foregoing, with respect to the 2013 calendar year, the Employee shall receive on
the Effective Date (i) a grant of stock options to acquire up to 10,000 shares of common stock of Parent (vesting annually 25% per year over a 4-year period), and (ii) a grant of 2,500 restricted shares of common stock of Parent
(vesting annually 25% per year over a 4-year period). 
 § 4c Company Car / Car Allowance 

The Employee will receive a Company car allowance equal to CHF 24.000.— gross per annum, i.e. CHF 2.000.— gross per month. 

The Orthofix Car Policy – Europe is applicable (see attachment). 

§ 4d Social Security 
 The legal regulations of
Switzerland apply (AHV, BVG, UVG, KTG). 

  
 Page 4 of 19 

			
	

	  	Employment Contract

  

 § 4e Insurances 

The Company shall take out accident insurance for the employee according to Swiss law and to the terms usually offered by the company. 

§ 5 Travel Expenses 
 Travel expenses, if appropriate
and occasioned by and in the interest of the Employer, will be reimbursed against proper receipts and in accordance with tax regulations as well as the Company Travel Policy. 

§ 6 Leave 
 The Employee is entitled to 25 work days
of leave for a full calendar year. Saturdays and Sundays are not considered work days in this regulation. 
 If the employment starts or ends during a
calendar year, the leave entitlement will be pro-rated, however not below the legal minimum. For the year 2013 the employee is entitled to 25 business days. 

Further details about the granting of leave are regulated in the Company Policy. 

§ 7 Inability to Work 
 The Employee is required to
inform the Employer via the direct line manager as well as HR immediately at the start of the inability to work, under specification of the reasons. If the inability is previously unknown, the Employer needs to be informed as soon as possible. 

If the inability to work is caused by sickness and the duration exceeds 2 days, the Employee is required to produce a doctor’s note before the end of the
third workday after the beginning of the inability to work, confirming the sickness as well as the expected duration. 
 § 8 Spare-time Work

 The employee agrees to dedicate his regular work hours fully to the employer, spare time work shall not conflict with the business interest of the
employer. 
 § 9a Non-Disclosure 
 The Employee is
obligated to keep business and company secrets as well as any information of confidential nature, which are verbally or in writing declared as such or if apparent as such, confidential and not disclose to any third party without prior consent of the
Company. 
 Business and Company secrets in this sense are especially non-public information about products, salaries, distribution channels, suppliers,
calculations, discounts, business deals, or other material information about the Company. In doubt the Employee is obligated to inquire with the Management if a certain fact is to be handled confidentially. 

  
 Page 5 of 19 

			
	

	  	Employment Contract

  

 This obligation is valid also after the end of the employment. Should this non-disclosure obligation hinder
the Employee in an inappropriate way after the end of the employment, the Employee is entitled to be relieved of this duty. 
 The Employee is aware of and
agrees to, that at the end of the employment, all rights of any kind to customers acquired by the Employee do not exist, and that no severance or compensation will be paid for existing or initiated customer relationships. 

For every case of breach of this non-disclosure agreement, the Employee is obligated to pay a contractual penalty in the amount of an average monthly base
salary (average of the last 12 months) to the Employer. This however does not eliminate the enforcement of further claims for damages. 
 § 9b
Non-Competition. 
 The non-competition agreement can be found in exhibit C in the attachment to this contract. 

§ 9c Obligation not to entice away Workforce in the Aftermath of the Employment Relationship 

The Employee agrees that for a period of one year after the termination of the Employment Contract the employee shall neither directly nor indirectly entice
away employees of the Company, its subsidiaries or parent company or cause them in any other way to leave the Company, its subsidiaries or parent company, if for that purpose the employee induces them to break the contract or uses information which
is subject to the post-contractual duty of secrecy. 
 The obligation not to entice away workforce also applies to the benefit of the Company’s
affiliated companies the Company dealt with either directly or indirectly. 
 Every time the Employee breaches the obligations described under in clause 9c,
the employee shall pay a contractual penalty in the amount of one monthly gross salary. The amount of the relevant monthly gross salary depends on the monthly gross salary including variable salary the Employee last received under this Employment
Contract. 
 The Company’s right to further damages shall not be affected. 

§10 Term of Preclusion 
 Any claim stemming from the
employment or any that are related to the employment, are required to be asserted inside the term of preclusion of 3 months for the respective claim from the other contractual party in writing, or they expire. 

If the opposing party declines the claim in writing or does not assert itself after one months of the initial assertion of the claim, then it expires if it is
not asserted after three months of the decline in front of a court. 
 These terms of preclusion do not apply to claims of damages of life, body or health,
as well as for damages resulting from deliberate or gross misconduct of either party. 

  
 Page 6 of 19 

			
	

	  	Employment Contract

  

 § 11 Application Information 

The Employee assures that all information provided during the hiring process is the truth and agrees to inform the Employer of any changes in this information
without delay. 
 § 12 Data Security 
 The employee
is prohibited to acquire, process or publish personal data, make it accessible or use in any other way than the lawful task fulfillment requires. As data processing in course of work may include the entry, recording, storing, over-transmit, modify,
delete, use, collection and freezing of personal data, the employee is hereby informed of the obligation to maintain confidentiality of personal data. The obligation of the employee to data secrecy continues even after the termination of employment.

 The employee expressly agrees that his personal data is stored, automated and processed. 

§ 13 Final Provisions 
 For all non-regulated
contractual areas the corresponding Swiss Code of Obligations applies. 
 Amendments and additions to this contract must be made in writing. This shall also
apply to the amendment of the clause requiring written form. 
 Verbal side-agreements do not exist. Further agreements than documented in this contract are
not agreed to. 
 Place of jurisdiction is Zug/Switzerland. 

If any provision of this agreement should be unlawful, void or unenforceable or should the contract contain a gap, the validity of the contract shall not be
affected. 
  

					
	 November 26, 2013
	 		 	November 18, 2013
	 Date
	 		 	Date
			
	ORTHOFIX AG	 		 	
			
	 /s/ Armin L. Landtwing
	 		 	/s/ Davide Bianchi
	 Armin L. Landtwing

Verwaltungsrat
	 		 	Davide Bianchi
			
	 /s/ Brad Mason
	 		 	
	 Brad Mason

CEO Orthofix International
	 		 	

  
 Page 7 of 19 

  
 

 
 EXHIBIT A 

RELEASE 
 In exchange for
the consideration set forth in the Employment Agreement, entered into and effective as of [     ], 2013, by and among Orthofix AG. (the “Company”) and myself (the “Employment Agreement”), the respective terms
of which are incorporated herein by reference, I, Davide Bianchi, am entering into this Release (this “Release”) for good and valuable consideration as required by the Employment Agreement, and agree as follows: 

1. GENERAL RELEASE. 
 (a) On behalf of myself, my heirs,
executors, successors and assigns, I and unconditionally release, waive and forever discharge the Company, its members, divisions, subsidiaries, affiliates and related companies, including the Company Group (as defined below), or any member of the
Company Group, and their present and former agents, employees, officers, directors, attorneys, stockholders, plan fiduciaries, successors and assigns (collectively, the “Releasees”), from any and all claims, demands, actions, causes of
action, costs, fees and all liability whatsoever, whether known or unknown, fixed or contingent, suspected or unsuspected (collectively, “Claims”), which I had, have, or may have against Releasees relating to or arising out of my
employment by or separation from the Company and its direct and indirect subsidiaries and parents, including, without limitation, Orthofix International N.V. (collectively, the “Company Group”), up to and including the date of execution of
this Release, other than my right to receive the severance payments and other benefits and consideration described in the Employment Agreement. This Release includes, without limitation: (i) claims at law or equity or sounding in contract
(express or implied) or tort; (ii) claims arising under any federal, state or local laws of any jurisdiction that prohibit age, sex, race, national origin, color, disability, religion, veteran or military status, sexual orientation or any other
form of discrimination, harassment or retaliation (including, without limitation, the Civil Rights Act of 1866, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Americans with Disabilities Act, Title VII of the
1964 Civil Rights Act, the Civil Rights Act of 1991, the Rehabilitation Act, the Family and Medical Leave Act, the Sarbanes-Oxley Act, the Employee Polygraph Protection Act, the Uniformed Services Employment and Reemployment Rights Act of 1994, the
Unruh Civil Rights Act, or any other federal, state or local laws, regulations and ordinances governing discrimination, harassment or retaliation in employment; and the right to bring demands, complaints, causes of action, and claims under any other
federal, state, local or common law, statute, regulation or decision); (iii) claims arising under the Employee Retirement Income Security Act; or (iv) any other statutory or common law claims related to my employment with the Company or my
separation from the Company. I further covenant not to sue any of the Releasees with respect to any matters released hereby. 
 (b) This release does not
include a release or waiver of any rights or claims I have, or might subsequently have in my capacity as a stockholder of Orthofix International N.V. In addition, this Release shall not release the Company from its continuing obligation to honor the
terms of the Employment Agreement. However, this Release shall remain in full force and effect regardless of any claim by me that the Company failed to honor the terms of the Employment Agreement. In the event of any such dispute, my sole remedy
against the Company shall be to enforce the terms of the Employment Agreement. I am also not waiving, and nothing in this Release is intended to waive, any right to coverage under any directors and officers insurance coverage, if any, provided by
the Company, the Company Group, or any member of the Company Group, or any right to indemnification or expense advancement under any indemnification agreement, or any applicable Company Group articles of incorporation, bylaws or similar
organizational document, if any, in each case, to which I might be entitled. I am also not waiving, and nothing in this Release is intended to waive any claims I may have for unemployment insurance or workers’ compensation benefits, state
disability compensation, claims for any vested benefits under any Company-sponsored benefit plan, or any claims that, as a matter of law, may not be released by private agreement. I am also not waiving, and nothing in this Release is intended to
waive, any claims relating to the validity or enforceability of this Release; or any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (the “EEOC”) or the National Labor Relations Board
(“NLRB”); provided, however, that I shall not be entitled to recover any monetary damages or to non-monetary relief if the EEOC or NLRB were to pursue any claims relating to my employment with the Company. 

  
 Page 8 of 19 

 

 
 EXHIBIT A 

RELEASE 
  

 EXCEPT AS OUTLINED ABOVE, THIS MEANS THAT, BY SIGNING THIS RELEASE, I WILL WAIVE ANY RIGHT I MAY HAVE HAD TO
PURSUE OR BRING A LAWSUIT OR MAKE ANY LEGAL CLAIM AGAINST THE COMPANY OR THE RELEASEES THAT IN ANY WAY ARISES FROM OR RELATES TO MY EMPLOYMENT OR THE TERMINATION OF THAT EMPLOYMENT, UP TO AND INCLUDING THE DATE OF THE EXECUTION OF THIS RELEASE. 

(c) I acknowledge that different or additional facts may be discovered in addition to what I now know or believe to be true with respect to the matters herein
released, and I agree that this Release shall be and remain in effect in all respects as a complete and final release of the matters released, notwithstanding any such different or additional facts. I represent and warrant that I have not previously
filed or joined in any claims against the Company or any of the Releasees, that I have not given or sold any portion of any claims released herein to anyone else, and that I will indemnify and hold harmless the Releasees from all liabilities,
claims, demands, costs, expenses and/or attorneys’ fees incurred as a result of any such assignment or transfer. 
 (d) I acknowledge that I have been
given an opportunity of [twenty one (21) / forty five (45) ] to consider this Release, but I may voluntarily waive that period by signing it earlier, and I acknowledge that I am being advised herein to consult with legal counsel of my own
choosing prior to executing this Release. I understand that for a period ending at the end of the seventh calendar day following my execution of this Release (“Revocation Period”), I shall have the right to revoke this Release by
delivering a written notice of revocation to Jeffrey M. Schumm, Orthofix Inc. Senior Vice President, General Counsel and Corporate Secretary, 3451 Plano Pkwy, Lewisville, TX 75056 no later than the end of the seventh calendar day after I sign this
Release. I understand and agree that this Release will not be effective and enforceable until after the Revocation Period expires without revocation, and if I elect to exercise this revocation right, this Release shall be voided in its entirety, and
the Company shall be relieved of all obligations under this Release and all obligations under the Employment Agreement as provided therein. This Release shall be effective on the eighth calendar day after it is executed by me (“Effective
Date”) provided it has not been previously revoked as provided herein. 
 2. I agree not to disclose, publish or use any confidential information of the
Company Group, except as the Company directs or authorizes unless required by law to do so. I also agree that I will take all reasonable measures to protect the secrecy of and avoid disclosure and unauthorized use of confidential information of the
Company Group, and I will immediately notify the Company in the event of any unauthorized use or disclosure of the Company Group’s confidential information of which I become aware. I agree that the obligations set forth in this paragraph do not
supersede, but are in addition to, any previous confidentiality obligations agreed to by me and any member of the Company Group, including those under the Agreement. The confidentiality provisions set forth in this Release are contractual and their
terms are material to this Release. In any proceeding brought to enforce or seek damages for the alleged breach of the confidentiality provisions of this Release, the party successfully prosecuting or defending such action shall be entitled to
recover from the opposing party its reasonable expenses, including attorneys’ fees. 
 3. I agree to hold harmless the Releasees, at my sole cost and
expense, from and against any claims arising from my breach of this Release (including breaches of my post separation obligations under the Agreement). 
 4.
I agree that I have not made and shall not make, publicly or privately, any critical or negative comments to the media or any significant critical or negative comments to any other person (including future or prospective employees) regarding any of
the Releasees. 

  
 Page 9 of 19 

 

 
 EXHIBIT A 

RELEASE 
  

 5. I understand it is my choice whether or not to enter into this Release and that my decision to do so is
voluntary and is made knowingly. 
 6. I represent and acknowledge that in executing this Release, I do not rely, and have not relied, on any communications,
statements, inducements or representations, oral or written, by any of the Releasees, except as expressly contained in this Release. 
 7. I also represent
and warrant that, on or before my last date of employment, I will have delivered to the Company (a) all documents and materials containing confidential information (including without limitation any “soft” copies or computerized or
electronic versions thereof) or otherwise containing information relating to the business and affairs of any member of the Company Group (whether or not confidential), and (b) all other documents, materials and other property belonging to any
member of the Company Group that are or were in my possession or under my control. 
 8. The Company and I agree that this Release shall be binding on us and
our heirs, administrators, representatives, executors, successors and assigns, and shall inure to the benefit of our heirs, administrators, representatives, executors, successors and assigns. 

9. This Release shall be interpreted under and governed by the laws of the State of Texas. The Company and I agree that the language of this Release shall in
all cases be construed as a whole, according to its fair meaning, and not strictly for or against either party. 
 10 The Company and I agree that should
that any provision of this Release be determined to be illegal or invalid, the validity of the remaining provisions will not be affected and any illegal or invalid provision will be deemed not to be a part of this Release. 

11. The Company and I agree that this Release may be executed in any number of counterparts, each of which shall be deemed an original, but all of which
together shall be deemed one and the same instrument. 
 Please read carefully as this document includes a General Release of claims. 

As evidenced by my signature below, I certify that I have read the above Release and agree to its terms. 

Accepted and Acknowledged: 
  

					
	 November 26, 2013
	 		 	November 18, 2013
	 Date
	 		 	Date
			
	ORTHOFIX AG	 		 	
			
	 /s/ Armin L. Landtwing
	 		 	/s/ Davide Bianchi
	 Armin L. Landtwing

Verwaltungsrat
	 		 	Davide Bianchi
			
	 /s/ Brad Mason
	 		 	
	 Brad Mason

CEO Orthofix International
	 		 	

  
 Page 10 of 19 

 

 
  

 EXHIBIT B 

DEFINITIONS 
 For purposes
of this Agreement, the following capitalized terms have the meanings set forth below: 
 “Board” shall mean the Board of Directors of
Parent. Any obligation of the Board other than termination for Cause under this Agreement may be delegated to an appropriate committee of the Board, including its compensation committee, and references to the Board herein shall be references to any
such committee, as appropriate. 
 “Cause” shall mean termination of the Employee’s employment because of the Employee’s:
(i) involvement in fraud, misappropriation or embezzlement related to the business or property of the Company; (ii) conviction for, or guilty plea to, or plea of nolo contendere to, a felony or crime of similar gravity in the jurisdiction
in which such conviction or guilty plea occurs; (iii) intentional wrongful disclosure of Confidential Information or other intentional wrongful violation of Article VI; (iv) willful and continued failure by the Employee to follow the
reasonable instructions of the Board or Chief Executive Officer; (v) willful commission by the Employee of acts that are dishonest and demonstrably and materially injurious to a member of the Parent Group, monetarily or otherwise;
(vi) willful or material violation of, or willful or material noncompliance with, any securities law, rule or regulation or stock exchange listing rule adversely affecting the Parent Group including without limitation (a) if the Employee
has undertaken to provide any certification or related back-up material required for the chief and principal executive and financial officers to provide a certification required under the Sarbanes-Oxley Act of 2002, including the rules and
regulations promulgated thereunder (the “Sarbanes-Oxley Act”), and he willfully or materially fails to take reasonable and appropriate steps to determine whether or not the certificate or related back-up material was accurate or otherwise
in compliance with the requirements of the Sarbanes-Oxley Act or (b) the Employee’s willful or material failure to establish and administer effective systems and controls applicable to his area of responsibility necessary for the Parent to
timely and accurately file reports pursuant to Section 13 or 15(d) of the Exchange Act. No act or omission shall be deemed willful or material for purposes of this definition if taken or omitted to be taken by Employee in a good faith belief
that such act or omission to act was in the best interests of the Parent Group or if done at the express direction of the Board. 
 “Change of
Control” shall occur upon any of the following events: 
 (i) the acquisition by any individual, entity or group of beneficial ownership, in any
individual transaction or series of related transactions, of 50% or more of either (A) the then outstanding shares of common stock of Parent (the “Outstanding Common Stock”) or (B) the combined voting power of the then
outstanding voting securities of Parent entitled to vote generally in the election of directors (the “Outstanding Voting Securities”); excluding, however, the following: (1) any acquisition directly from Parent,
other than an acquisition by virtue of the exercise of a conversion privilege unless the security being so converted was itself acquired directly from Parent; (2) any acquisition by Parent; (3) any acquisition by any employee benefit plan
(or related trust) sponsored or maintained by Parent or any entity controlled by Parent; or (4) any acquisition pursuant to a transaction which complies with clauses (A), (B) and (C) of subsection (iii) of this definition of
Change of Control; 
 (ii) a change in the composition of the Board such that the individuals who as of the Effective Date constitute the Board (the
“Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, for purposes of this paragraph, that any individual who becomes a member of the Board subsequent to the
Effective Date, whose appointment, election, or nomination for election by Parent’s shareholders was approved by a vote of at least a majority of those individuals who are members of the Board and who were also members of the Incumbent Board
(or deemed to be such pursuant to this proviso) shall be considered as though such individual were a member of the Incumbent Board; but 

  
 Page 11 of 19 

 

 
 EXHIBIT B 

DEFINITIONS 
  

 
provided further that any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of
Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board shall not be so considered as a member of the Incumbent Board; 

(iii) consummation of a reorganization, merger, consolidation or other business combination or the sale or other disposition of all or substantially all of the
assets of Parent (including assets that are shares held by Parent in its subsidiaries) (any such transaction, a “Business Combination”); expressly excluding, however, any such Business Combination pursuant to which all
of the following conditions are met: (A) all or substantially all of the Person(s) who are the beneficial owners of the Outstanding Common Stock and Outstanding Voting Securities, respectively, immediately prior to such Business Combination
will beneficially own, directly or indirectly, more than 50% of, respectively, the outstanding shares of common stock, and the combined voting power of the outstanding voting securities entitled to vote generally in the election of directors, as the
case may be, of the entity resulting from such Business Combination (including, without limitation, an entity which as a result of such transaction owns Parent or all or substantially all of Parent’s assets either directly or through one or
more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Outstanding Common Stock and Outstanding Voting Securities, as the case may be, (B) no Person (other than
Parent, any employee benefit plan (or related trust) of Parent or such entity resulting from such Business Combination) will beneficially own, directly or indirectly, 50% or more of, respectively, the outstanding shares of common stock of the entity
resulting from such Business Combination or the combined voting power of the outstanding voting securities of such entity entitled to vote generally in the election of directors except to the extent that such ownership existed prior to the Business
Combination, and (C) individuals who were members of the Incumbent Board will constitute at least a majority of the members of the board of directors of the entity resulting from such Business Combination; 

(iv) the approval by the shareholders of Parent of a complete liquidation or dissolution of Parent; 

(v) the Parent Group (or any of them) shall sell or dispose of, in a single transaction or series of related transactions, business operations that generated
two-thirds of the consolidated revenues of the Parent Group (determined on the basis of Parent’s four most recently completed fiscal quarters for which reports have been filed under the Exchange Act) and such disposal shall not be exempted
pursuant to clause (iii) of this definition of Change of Control; 
 (vi) Parent files a report or proxy statement with the Securities and Exchange
Commission pursuant to the Exchange Act disclosing in response to Form 8-K or Schedule 14A (or any successor schedule, form or report or item therein) that a change of control of Parent has or may have occurred or will or may occur in the future
pursuant to any then-existing agreement or transaction; notwithstanding the foregoing, unless determined in a specific case by a majority vote of the Board, a “Change of Control” shall not be deemed to have occurred solely because:
(A) an entity in which Parent directly or indirectly beneficially owns 50% or more of the voting securities, or any Parent-sponsored employee stock ownership plan, or any other employee plan of Parent or the Company, either files or becomes
obligated to file a report or a proxy statement under or in response to Schedule 13D, Schedule 14D-1, Form 8-K or Schedule 14A (or any successor schedule, form or report or item therein) under the Exchange Act, disclosing beneficial ownership by
form or report or item therein, disclosing beneficial ownership by it of shares of stock of Parent, or because Parent reports that a change of control of Parent has or may have occurred or will or may occur in the future by reason of such beneficial
ownership or (B) any Parent-sponsored employee stock ownership plan, or any other employee plan of Parent or the Company, either files or becomes obligated to file a report or a proxy statement under or
in response to Schedule 13D, Schedule 14D-1, Form 8-K or Schedule 14A (or any 

  
 Page 12 of 19 

 

 
 EXHIBIT B 

DEFINITIONS 
  

 
successor schedule, form or report or item therein) under the Exchange Act, disclosing beneficial ownership by form or report or item therein, disclosing beneficial ownership by it of shares of
stock of Parent, or because Parent reports that a change of control of Parent has or may have occurred or will or may occur in the future by reason of such beneficial ownership; or 

(vii) any other transaction or series of related transactions occur that have substantially the effect of the transactions specified in any of the preceding
clauses in this definition. 
 Notwithstanding the above definition of Change of Control, the Board, in its sole discretion, may determine that a Change of
Control has occurred for purposes of this Agreement, even if the events giving rise to such Change of Control are not expressly described in the above definition. 

“Change of Control Date” shall mean the date on which a Change of Control occurs. 

“Change of Control Period” shall mean the 24 month period commencing on the Change of Control Date; provided, however, if the Company
terminates the Employee’s employment with the Company prior to the Change of Control Date but on or after a Potential Change of Control Date, and it is reasonably demonstrated that the Employee’s (i) employment was terminated at the
request of an unaffiliated third party who has taken steps reasonably calculated to effect a Change of Control or (ii) termination of employment otherwise arose in connection with or in anticipation of the Change of Control, then the
“Change of Control Period” shall mean the 24 month period beginning on the date immediately prior to the date of the Employee’s termination of employment with the Company. 

“Competing Business” means any business or activity that (i) competes with any member of the Parent Group for which the Employee
performed services or the Employee was involved in for purposes of making strategic or other material business decisions and involves (ii) (A) the same or substantially similar types of products or services (individually or collectively)
manufactured, marketed or sold by any member of the Parent Group during Term or (B) products or services so similar in nature to that of any member of the Parent Group during Term (or that any member of the Parent Group will soon thereafter
offer) that they would be reasonably likely to displace substantial business opportunities or customers of the Parent Group. 
 “Confidential
Information” shall include Trade Secrets and includes information acquired by the Employee in the course and scope of his activities under this Agreement, including information acquired from third parties, that (i) is not generally
known or disseminated outside the Parent Group (such as non-public information), (ii) is designated or marked by any member of the Parent Group as “confidential” or reasonably should be considered confidential or proprietary, or
(iii) any member of the Parent Group indicates through its policies, procedures, or other instructions should not be disclosed to anyone outside the Parent Group. Without limiting the foregoing definitions, some examples of Confidential
Information under this Agreement include (a) matters of a technical nature, such as scientific, trade or engineering secrets, “know-how”, formulae, secret processes, inventions, and research and development plans or projects regarding
existing and prospective customers and products or services, (b) information about costs, profits, markets, sales, customer lists, customer needs, customer preferences and customer purchasing histories, supplier lists, internal financial data,
personnel evaluations, non-public information about medical devices or products of any member of the Parent Group (including future plans about them), information and material provided by third parties in confidence and/or with nondisclosure
restrictions, computer access passwords, and internal market studies or surveys and (c) and any other information or matters of a similar nature. 

  
 Page 13 of 19 

 

 
 EXHIBIT B 

DEFINITIONS 
  

 “Exchange Act shall mean the Securities Exchange Act of 1934, or amended. 

“Good Reason” shall mean the occurrence of any of the following without the written consent of the Employee: (1) the
assignment to the Employee of any duties materially inconsistent in any respect with the Employee’s position (including status, offices, titles and reporting requirements), authority, duties or responsibilities as contemplated by this
Agreement, or any other action by the Company which results in a material diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and
which is remedied by the Company promptly after receipt of notice thereof given by the Employee; (2) the Company’s material reduction of the Employee’s Base Salary or bonus opportunity, each as in effect on the date hereof or as the
same may be increased from time to time; (3) the Company’s failure to obtain a satisfactory agreement from any successor entity to assume and agree to perform this Agreement; or (4) any material breach of this Agreement or any other
material agreement with the Employee by the Company or any successor entity. 
 “Parent” shall mean Orthofix International N.V., an entity
organized under the laws of Curacao. 
 “Parent Group” shall mean Parent, together with its subsidiaries including the Company. 

“Person” shall include individuals or entities such as corporations, partnerships, companies, firms, business organizations or enterprises,
and governmental or quasi-governmental bodies. 
 “Potential Change of Control” shall mean the earliest to occur of: (i) the date on
which Parent executes an agreement or letter of intent, the consummation of the transactions described in which would result in the occurrence of a Change of Control or (ii) the date on which the Board approves a transaction or series of
transactions, the consummation of which would result in a Change of Control, and ending when, in the opinion of the Board, the Parent (or the Company) or the respective third party has abandoned or terminated any Potential Change of Control. 

“Potential Change of Control Date” shall mean the date on which a Potential Change of Control occurs; provided, however, such date shall
become null and void when, in the opinion of the Board, the Parent (or the Company) or the respective third party has abandoned or terminated any Potential Change of Control. 

“Trade Secrets” are information of special value, not generally known to the public that any member of the Parent Group has taken steps to
maintain as secret from Persons other than those selected by any member of the Parent Group. 

  
 Page 14 of 19 

 

 
  

 EXHIBIT C 

NON-COMPETITION AGREEMENT 

 

			
	 OPZIONE PER UN PATTO DI NON CONCORRENZA
  

Tra
  

Orthofix AG
 c/o ALLconsultServices

Bundesstrasse 3
 CH-6304 Zug

 
 E
  

Il Mr. Davide Bianchi, residente in Ch. Du Mont Blanc 4, 1272 Genolier, Vaud- Svizzera (di seguito “Dirigente”)

 
 Di seguito denominate “le Parti”

Premesso che
  

i)       La Società e il Gruppo cui essa appartiene (con il termine
“Gruppo” si intende includere la Società, la sua controllante e tutte le società dalle stesse direttamente o indirettamente controllate o partecipate) ricoprono una posizione leader a livello mondiale nel settore delle
Tecnologie Medicali. In particolare il Gruppo si occupa di sviluppo, della produzione, e della vendita di prodotti nei seguenti segmenti del mercato: tutti i prodotti alla gamma di « Extremity Fixation »

 
 ii)     il Dirigente
è stato assunto dalla Società dal giorno 22 July 2013 con la posizione di Presidente Internazionale della fissazione esterna (di seguito il “Rapporto di Lavoro”;

 
 iii)    nel corso del
Rapporto di Lavoro il Dirigente verrà a conoscenza di informazioni riservate riguardanti la Società e il Gruppo, nonché i prodotti della Società e del Gruppo, che rivestono primaria importanza per lo svolgimento
dell’attività di impresa della Società;
  

iv)    la Società e il Gruppo intendono tutelare i loro interessi in relazione alle
attività e agli incarichi che il Dirigente potrebbe svolgere in concorrenza con la Società successivamente alla cessazione del Rapporto di Lavoro.
	  	 OPTION OF NON-COMPETITION AGREEMENT
  

Between
  

Orthofix AG
 c/o ALLconsultServices

Bundesstrasse 3
 CH-6304 Zug

 
 And
  

Il Mr. Davide Bianchi, residente in Ch. Du Mont Blanc 4, 1272 Genolier, Vaud- Svizzera (below “Manager”)

 
 Hereinafter mentioned as “Parties”

WHEREAS
  

i)       The Company and the Group to which it belongs, (Group intended to include
the Company, its holding company, and all companies directly or indirectly controlled by the same or associated), cover a worldwide leading position in the field of Medical Technologies. In particular, the Group is engaged in the development,
production and sales of products in the following market sector: all products in the Product Range “Extremity Fixation”
  

ii)     The Manager has been employed by the Company since 22 July 2013, for the
position of President of International Extremity Fixation (hereinafter “The Employment Relationship”);
  

iii)    In the course of the Employment Relationship Manager will be aware of confidential
information regarding the Company and the Group, as well as the products of the Company and the Group, which are of major importance for the conduct of the business of the Company;

 
 iv)    The Company and the
Group wish to protect their interests in relation to the activities and the tasks that the Manager could carry out in competition with the Company subsequent to the termination of the Employment Relationship.

  
 Page 15 of 19 

 

 
 EXHIBIT C 

NON-COMPETITION AGREEMENT 

 

			
	 Ciò premesso, le Parti convengono quanto segue:
  

1) OPZIONE- EFFICACIA E CONDIZIONE SOSPENSIVA:
  

1.1. Il Dirigente concede alla Società un’opzione per la conclusione di un patto di non concorrenza nei termini e alle condizioni specificati al
successivo paragrafo 4 (qui di seguito l’Opzione).
  
 1.2. La Società accetta
l’Opzione e si impegna ad esercitarla nei termini e alle condizioni specificati al successivo paragrafo 2.
  
	  	 Accordingly the Parties agree as follows:
  

1) OPTION- EFFECTIVENESS AND SUSPENSION CONDITION:
  

1.1. The Manager, grants to the Company an option for the conclusion of a non-competition agreement, under the terms and conditions specified in the following
paragraph 4 (hereinafter “the Option”);
  
 1.2. The Company accepts and agrees
to exercise the option according to the terms and condition specified in paragraph 2.
  

	 2) ESERCIZIO DELL’OPZIONE
  

2.1 La Società potrà esercitare l’Opzione in ogni momento nel corso del Rapporto di Lavoro.

 
 2.2. La volontà della Società di esercitare l’Opzione e, di
conseguenza, di concludere il patto di non concorrenza di cui al successivo paragrafo 4, dovrà essere comunicata ad Dirigente per iscritto.
  
	  	 2) OPTION EXERCISE
  

2.1 The Company may exercise the option at any time during the Employment Relationship;

 
 2.2. The intention of the Company to exercise the Option and, therefore, to conclude the
non-competition agreement, referred to in paragraph 4, shall be notified to the manager in written form.
  

	 3) CORRISPETTIVO PER L’OPZIONE
  

A titolo di corrispettivo per la concessione dell’Opzione la Società Le corrisponderà un importo lordo pari a Euro 5000,—, in tre
tranche di uguale importo e unitamente alle competenze dei tre mesi successivi alla sottoscrizione della presente Opzione. Resta inteso e convenuto che il predetto importo si intende già comprensivo di ogni incidenza su tutti gli istituti
contrattuali e di legge, e che non sarà considerato retribuzione utile ai fini del calcolo del Trattamento di Fine Rapporto e degli istituti ad esso collegati.
	  	 3) PAYMENT AGREEMENT
  

For the grant of the Option, the Company will correspond a gross amount of € 5,000.00, in three installments each of the same amount and together with the
payment of three months’ remuneration after the signature of the present otion. It is agreed that said amount already includes any effect on any contractual and legal obligations, and that compensation will not be considered useful for the
calculating severance indemnities and institutions connected to it.

  
 Page 16 of 19 

 

 
 EXHIBIT C 

NON-COMPETITION AGREEMENT 

 

			
	 4) REGOLAMENTAZIONE DEL PATTO DI NON CONCORRENZA
  

4.1 Qualora la Società eserciti l’Opzione secondo i termini e alle condizioni di cui al precedente paragrafo 2, per un periodo di 12 mesi (dodici)
decorrente dalla data di effettiva cessazione del Rapporto di Lavoro (a prescindere dalle ragioni di tale cessazione) il Dirigente si impegna a non prestare la sua opera, direttamente o indirettamente, in favore di soggetti terzi, né a
svolgere attività in qualità di titolare, socio, dipendente, lavoratore autonomo o agente, nel campo dei Orthofix prodotti alla gamma di « Extremity Fixation »su tutto il territorio dell’Unione Europea e degli Stati
Uniti d’America.
  
 4.2. Il Dirigente si impegna inoltre a non distrarre e/o
stornare clienti con i quali ella abbia trattato, direttamente o indirettamente, negli ultimi tre anni del Rapporto di Lavoro. Il Dirigente si asterrà altresì dal distrarre e/o stornare dipendenti o altri collaboratori della
Società, nonché dall’indurli a cessare il loro rapporto di collaborazione con la Società stessa.
  

4.3. Al fine di consentire alla Società un adeguato controllo sul rispetto del patto di non concorrenza da parte del Dirigente, quest’ultimo si
impegna a fornire alla Società tutte le informazioni rilevanti riguardanti le attività lavorative e professionali che la stessa svolgerà durante il periodo di validità del patto di non concorrenza. Tali informazioni
verranno comunicate per iscritto e anteriormente all’effettivo svolgimento delle predette attività. Il Dirigente si impegna altresì ad informare anticipatamente il proprio nuovo datore di lavoro e/o committente dell’esistenza
del presente patto di non concorrenza, del quale il Dirigente è autorizzato a fornire copia.
	  	 4) REGULATION OF NON-COMPETITION AGREEMENT
  

4.1. If the Company exercises the Option in accordance with the terms and conditions referred to paragraph in 2 above, for a period of 12 months (twelve
months) from the effective date of termination of the Employment Relationship (independently from the reason of termination of the employment relation) the Manager agrees not to provide his work, directly or indirectly, in favor of third parties, or
engage as owner, partner, employee, self-employed or agent, in the field of the Orthofix Portfolio “Extremity Fixation” on the whole territory of the European Union and the United States of America.

 
 4.2 The Manager agrees not to distract or divert a customer to whom he has dealt with,
directly or indirectly, in the last three years of the Employment Relationship.. The Manager will also refrain from distracting and/or divert employees or other employees of the Company and from inducing them to cease their relationship with the
Company.
  
 4.3. In order to allow the Company an adequate monitoring compliance with the
non-competition agreement by the Manager, the latter undertakes to provide the Company with all relevant information concerning the business and professional activities that take place during the same period of validity of the non-competition
agreement.
  
 These informations have to be communicated in written form and prior to the
actual performance of said activities. The Manager has to inform in advance his new employer of the existence of this non-competition agreement. The Manager is authorized to provide a copy of this contract to his employer.

  
 Page 17 of 19 

 

 
 EXHIBIT C 

NON-COMPETITION AGREEMENT 

 

			
	 4.4. Ogni singola violazione, da parte del Dirigente, degli obblighi di non concorrenza di cui al presente paragrafo 4, comporterà il
pagamento, da parte del Dirigente stesso, di una penale pari ad Euro 150.000 senza alcun pregiudizio per il diritto della Società al risarcimento dell’eventuale maggior danno. Al verificarsi della violazione, e fermo restando il
pagamento della penale di cui sopra, la Società avrà la facoltà di risolvere il patto di non concorrenza per inadempimento o di continuare a chiederne il corretto adempimento da parte del Dirigente. In questo caso è fatto
salvo il diritto del Dirigente al corrispettivo ancora eventualmente dovuto ai sensi del successivo paragrafo 5.1. In caso di risoluzione, il Dirigente, oltre a corrispondere la penale di cui sopra, sarà tenuta a restituire alla
Società il corrispettivo eventualmente già percepito ai sensi di quanto previsto al successivo paragrafo 5.1.
  

4.5 Resta inteso che la Società potrà decidere di non esercitare l’Opzione. In questo caso, il patto di non concorrenza come regolato al
presente paragrafo 4 non entrerà in vigore e non produrrà nessun effetto, e al dirigente non spetterà alcun corrispettivo ai sensi di quanto previsto al successivo paragrafo 5.1.

 
 5) CORRISPETTIVO PER IL PATTO DI NON CONCORRENZA

 
 5.1 Tenuto conto del background professionale del Dirigente, le Parti convengono che un
corrispettivo per il predetto patto di non concorrenza pari al 70% della retribuzione fissa annua lorda in vigore al momento della cessazione del Rapporto di lavoro, sia equo e ragionevole.

 
 5.2. Il corrispettivo di cui al presente paragrafo 5.1. verrà corrisposto in due
rate di pari importo come segue:
  
 - il 50% entro e non oltre sette mesi dalla data di
entrata in vigore del patto;
  
 - il residuo 50% entro e non oltre il mese successivo
alla data di termine del patto.
	  	 4.4. For each violation incurred by the Manager, of this non-compete option, according to what referred to in this paragraph 4, the Manager
will pay to the Company, a penalty of Euros 150,000.00 without prejudice to compensation for further damages to the Company. Upon occurrence of the violation, and without prejudice of payment of the abovementioned penalty, The Company will have the
right to terminate the non-competition agreement for non-performance or to continue to ask for the proper performance by the Manager.. In this case, the Manager is entitled to the payment, as defined in paragraph 5.1..

 
 In case of termination of the contract, the Manager will have to pay the penalty, and will
have to return back to the Company the amount he has already received under the provisions of paragraph 5.1.
  

4.5. It is understood that the Company may decide not to exercise the option. In this case, the non-competition agreement, as regulated in this Paragraph 4,
will not produce any effect, and the Manager will not receive any payment, as defined in paragraph 5.1.
  

5) PAYMENT FOR NON-COMPETITION AGREEMENT
  

5.1. According to the professional background of the Manager, the Parties agree that a remuneration for the non-competition agreement of 70% of annual gross
salary in force at the time of the termination of the employment relationship, is fair and reasonable.
  

5.2. The remuneration, referred to in this paragraph 5.1., will be paid in two installments as follows:

 
 - 50% no later than seven months from the date of entry into force of the agreement;

 
 - The remaining 50% within and no later than the month following the date of termination
of the agreement.

  
 Page 18 of 19 

 

 
 EXHIBIT C 

NON-COMPETITION AGREEMENT 

 

					
	November 26, 2013	 		 	November 18, 2013
	Date	 		 	Date
			
	 ORTHOFIX AG
  

/s/ Armin L. Landtwing
	 		 	/s/ Davide Bianchi
	 Armin L. Landtwing

Verwaltungsrat
	 		 	Davide Bianchi
			
	/s/ Brad Mason	 		 	
	 Brad Mason
 CEO Orthofix International
	 		 	

  
 Page 19 of 19EX-10.1

 Exhibit 10.1 
  

 
 January 6, 2014 
 Arthur
Krieg, M.D. 
 49 Trowbridge St., #3 
 Cambridge, MA 02138 

Dear Art: 
 We are pleased to offer you a position as Senior
Vice President, Chief Scientific Officer at Sarepta Therapeutics, Inc. (the “Company”), reporting to Chris Garabedian, President and Chief Executive Officer (“CEO”), pursuant to the terms set forth in this letter
agreement, effective January 13, 2014 (“Start Date”). Your employee orientation will begin at 11:00 a.m. on your Start Date at our Cambridge office, 215 First Street, Suite 7, Cambridge, Massachusetts. 

 

	 	1.	Employment At-Will. 

 If you accept our offer of employment, you will be an employee at-will, meaning
that your employment is of indefinite duration and either you or the Company may terminate our employment relationship at any time for any reason, with or without cause and with or without advance notice. However, you may be entitled to severance
benefits as detailed below depending on the circumstances of your termination of employment with the Company. In the event of your resignation, we request that you give the Company at least two weeks’ notice. 

 

	 	2.	Compensation. 

 (a) Base Salary. The Company will pay you an annual salary of
$418,000 as compensation for your services (the “Base Salary”). The Base Salary will be paid periodically in accordance with the Company’s normal payroll practices and be subject to the usual, required withholdings. Your salary
will be subject to review and adjustments will be made based upon the Company’s normal performance review practices. 
 (b) Target
Bonus. You will be eligible to receive a target annual bonus of forty percent (40%) of your Base Salary, less applicable withholdings (“Target Bonus”). Your actual bonus in any given year may range from 0% to 150% of your
Target Bonus, based upon achievement of a combination of company and individual objectives as determined by the CEO and the Board of Directors (the “Board”) in their sole discretion. Employees who join the company after
September 30, 2013, are not eligible to receive a 2013 Bonus. Employees who join the company between January 1, 2014 and September 30, 2014 will be eligible for a prorated bonus for 2014 as described above based on company and
individual performance as determined by the CEO and the Board. 
 (c) Equity Awards. We will recommend to the Compensation Committee
of our Board of Directors that you receive an executive inducement grant of options to purchase 275,000 shares of the Company’s common stock (the “Option”). The grant will be subject to the approval of the Company’s
Compensation Committee or its delegate. Your grants will be subject to the terms, 

 
definitions and provisions of the Executive Inducement Stock Option Agreement by and between you and the Company (the “Option Agreement”) which Option Agreement is incorporated
herein by reference. Twenty-five percent (25%) of the shares underlying the Option will vest on the one (1) year anniversary of the Start Date, and 1/48th of the shares underlying the
Option will vest on each monthly anniversary of the Start Date thereafter, such that the shares underlying the Option will be fully exercisable on the fourth annual anniversary of the Start Date, subject to your continued employment through any such
anniversary dates. Shares shall only vest on such dates; no rights to any vesting shall be earned or accrued prior to such dates. 
 The date for annual
equity grants has not yet been determined for 2014. However, effective 2014 and beyond, Sarepta employees will have to be on board for at least five months prior to the annual equity grant date in order to be eligible for an annual grant. If you are
eligible for a 2014 grant, the size of the grant will be prorated to reflect the number of complete months you have been employed with the Company at the time of the grant. Beginning in 2015 you will be eligible for a full annual grant provided you
are an employee of the Company at the time of the grant. Notwithstanding the foregoing, any and all annual grants (including, without limitation, eligibility, amounts and grant dates, if any) will be subject to the applicable equity plan provisions
and approval of the Compensation Committee of the Company’s Board of directors. 
 (d) Parking. Onsite parking at the Cambridge
location is available through Laz Parking (ww.lazparking.com). If you elect to park in this lot, you must first fill out the appropriate paperwork and register with Laz Parking. The Company will reimburse your Laz Parking expenses up to a maximum of
$130 per month, which is fifty percent (50%) of the current monthly Laz Parking fee, in accordance with the Company’s expense reimbursement policy. 

(e) Other Employee Benefits. During your employment with the Company, you will be entitled to participate in the employee benefit
plans currently and hereafter maintained by the Company of general applicability to other executive officers of the Company, including without limitation any annual equity grants. None of the benefits offered to you by the Company create a right to
continue in employment for any particular period of time. Any statements to the contrary that may have been made to you are unauthorized and are superseded and cancelled by this offer letter. Please also remember that employment terms like your
position, hours of work, work location, compensation, the stock option plan, and other employee benefits may change over the course of employment at the Company’s discretion. 

 

	 	3.	Severance Benefits. 

 Following commencement of your employment with the Company you will be eligible to
enter into the Company’s standard Change in Control Agreement. This agreement will outline your severance benefits in the event of Involuntary Termination following a Change in Control. 

 

	 	4.	Proprietary Rights Agreement. 

 As a condition of your employment, you are required to sign a
Confidential Proprietary Rights and Non-Disclosure Agreement (“Confidentiality Agreement”). The Confidentiality Agreement is enclosed to give you an opportunity to read it carefully prior to your hire date. You must sign the
Confidentiality Agreement on or before your Start Date as a condition of employment. 

 We need to emphasize the importance we place on the proper treatment of all proprietary information, including
that which you may have come into contact with in your prior employment. The Company is extending this offer to you based upon your general skills and abilities, and not your possession of any trade secret, confidential or proprietary information of
a former employer. The Company requires that you do not obtain, keep, use for our benefit, or disclose this type of information from any prior employers to us. By accepting this offer, you will also be affirming to the Company that you are not a
party to any agreement with a prior employer that would prohibit your employment with us. 
 Moreover, you agree that during the term of your employment,
you will not engage in any other employment, occupation, consulting, or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any
other activities that conflict with your obligations to the Company. 
  

	 	5.	Background Investigation/Reference Checks. 

 As a part of the employment process, we reserve the right to
conduct background investigations and/or reference checks on all potential employees to the fullest extent permitted under applicable law. Your job offer, therefore, is contingent upon a clearance of such background investigation and/or reference
check. 
  

	 	6.	Eligibility for Employment. 

 The United States government requires all U.S. employers to verify that
employees are eligible to work in the United States. This law applies to citizens and non-citizens. Enclosed is a list of documents that are acceptable for completing the employment verification (Form 1-9) process. Please bring your documentation
with you on your first day. The law requires that such documentation be provided within 3 business days of the effective date of your employment, or your employment relationship with the Company may be terminated. In addition, since the Company is a
Federal contractor, please note that we participate in e-Verify (an online work authorization verification system). 
  

	 	7.	Miscellaneous. 

 This letter will be governed by the laws of the State of Massachusetts. This letter, the
Equity Agreements and the Confidentiality Agreement, set forth the terms of your employment with the Company and supersede any prior representations or agreements including, but not limited to, any representations made during your interviews or
relocation negotiations, whether written or oral. This letter, including, but not limited to, its at-will employment provision, may not be modified or amended except by a written agreement signed by the Company CEO and you. 

If you wish to accept employment with Sarepta Therapeutics, please sign this letter and return one copy to me. This offer will remain open through
January 12, 2014. 

 We are pleased to welcome you to Sarepta Therapeutics. If you have any questions, please give me a call at
857-242-3101. 
 Sincerely, 
 /s/ Chris Garabedian 

Chris Garabedian 
 President & Chief Executive Officer

 AGREED TO AND ACCEPTED: 
 I accept the above
written offer of employment under the terms in this letter. 
  

							
	 Signature
	 	 /s/ Arthur Krieg        
	  		  	 Date: January 7, 2014

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}]]